Cu (I)-catalyzed click chemistry in glycoscience and their diverse applications

AK Agrahari, P Bose, MK Jaiswal, S Rajkhowa… - Chemical …, 2021 - ACS Publications
Copper (I)-catalyzed 1, 3-dipolar cycloaddition between organic azides and terminal
alkynes, commonly known as CuAAC or click chemistry, has been identified as one of the …

[HTML][HTML] CuAAC-ensembled 1, 2, 3-triazole-linked isosteres as pharmacophores in drug discovery

A Rani, G Singh, A Singh, U Maqbool, G Kaur… - RSC advances, 2020 - pubs.rsc.org
The review lays emphasis on the significance of 1, 2, 3-triazoles synthesized via CuAAC
reaction having potential to act as anti-microbial, anti-cancer, anti-viral, anti-inflammatory …

A comprehensive review of N-heterocycles as cytotoxic agents

D Kumar, S Kumar Jain - Current Medicinal Chemistry, 2016 - ingentaconnect.com
Scientific community is striving to understand the role of heterocycles and fused
heterocycles in drug discovery programme due to its impact on multi-drug resistance (MDR) …

Robust and Versatile Cu (I) metal frameworks as potential catalysts for azide-alkyne cycloaddition reactions

P Saini, G Singh, G Kaur, J Singh, H Singh - Molecular Catalysis, 2021 - Elsevier
Abstract The use of 'Click Reaction'for Cu (I) catalyzed azide–alkyne cycloaddition (CuAAC)
has emerged as one of the most powerful tools for the synthesis of library of organic …

One‐pot synthesis and biological evaluation of novel 4‐[3‐fluoro‐4‐(morpholin‐4‐yl)]phenyl‐1H‐1,2,3‐triazole derivatives as potent antibacterial and anticancer …

S Narsimha, SK Nukala… - Journal of …, 2020 - Wiley Online Library
In search of better antibacterial and anticancer agents, a series of novel 4‐[3‐fluoro‐4‐
(morpholin‐4‐yl)] phenyl‐1 H‐1, 2, 3‐triazole derivatives were synthesized (6a‐l and 8a‐j) …

A recent review on drug modification using 1, 2, 3-triazole

A Sahu, P Sahu, R Agrawal - Current Chemical Biology, 2020 - ingentaconnect.com
Motivated by evidence garnered from literature probing the use of triazoles in drug discovery
and development, we reported the utilization of bioisosteric replacement and molecular …

Design, synthesis and biological evaluation of novel 1, 2, 3-triazole-based xanthine derivatives as DPP-4 inhibitors

S Narsimha, KS Battula, M Ravinder, YN Reddy… - Journal of Chemical …, 2020 - Springer
Inhibitors of dipeptidyl peptidase-4 (DPP4) have been shown to be effective treatments for
type 2 diabetes. A series of novel 1, 2, 3-triazole based xanthine derivatives were designed …

Microwave-assisted Cu-catalyzed C–C bond formation: one-pot synthesis of fully substituted 1, 2, 3-triazoles using nonsymmetrical iodoalkynes and their biological …

S Narsimha, KS Battula, YN Reddy… - Chemistry of Heterocyclic …, 2018 - Springer
A copper-catalyzed one-pot synthesis of fused benzothiazino [1, 2, 3] triazolo [4, 5-c]
quinolinone derivatives from 1-iodoalkynes with different aryl azides via an in situ generated …

Synthesis, characterization and biological evaluation of 7-substituted-4-((1-aryl-1H-1, 2, 3-triazol-4-yl) methyl)-2H-benzo [b][1, 4] oxazin-3 (4H)-ones as anticancer …

VR Nagavelli, SK Nukala, S Narsimha… - Medicinal Chemistry …, 2016 - Springer
Abstract A series of novel 1, 2, 3-triazole-2H-benzo [b][1, 4] oxazin-3 (4H)-ones (4a–4k and
5a–5g) were designed, synthesized and screened for their anticancer activity against MCF-7 …

One-pot synthesis of novel 1, 2, 3-triazole-pyrimido [4, 5-c] isoquinoline hybrids and evaluation of their antioxidant activity

S Narsimha, KS Battula, VR Nagavelli - Synthetic Communications, 2018 - Taylor & Francis
ABSTRACT A series of novel pyrimido [4, 5-c] isoquinolines (3a–3h) and 1, 2, 3-triazole-
coupled pyrimido [4, 5-c] isoquinolines (4a–4h) were synthesized in good to excellent yields …